Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction

Hepatocellular carcinoma is a leading cause of mortality worldwide, and its incidence is rising. The last few years have witnessed a proliferation of available systemic therapeutic options, with the approval of multiple agents, including immune checkpoint inhibitors and drugs targeting vascular endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Surabhi, Sonbol, Mohamad Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464222/
https://www.ncbi.nlm.nih.gov/pubmed/34584898
http://dx.doi.org/10.2147/JHC.S268314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464222/
https://www.ncbi.nlm.nih.gov/pubmed/34584898
http://dx.doi.org/10.2147/JHC.S268314

Ejemplares similares